borderline significantp < 0.052
Paclitaxel did not reduce the tumour volume with the same potency as carboplatin, but treatment with the highest concentration (10 μg/mL) caused a regression of the tumours that was borderline significant ( p < 0.052) (Fig. 1c, e ).